Pancreatitis in a 57-Year-Old Female Two Weeks After Initiation of Empagliflozin

BACKGROUND/OBJECTIVE: Pancreatitis is a common diagnosis requiring hospital admission, associated with significant costs. Although pancreatitis is an established side-effect with other diabetes medications, such as Glucagon like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase 4 inhibitors, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Poloju, Alekya, Majety, Priyanka, Groysman, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Clinical Endocrinology 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382614/
https://www.ncbi.nlm.nih.gov/pubmed/37520757
http://dx.doi.org/10.1016/j.aace.2023.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382614/
https://www.ncbi.nlm.nih.gov/pubmed/37520757
http://dx.doi.org/10.1016/j.aace.2023.04.005

Ejemplares similares